IBDEI0D0 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13009,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,13009,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,13010,0)
 ;;=G30.8^^58^675^1
 ;;^UTILITY(U,$J,358.3,13010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13010,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,13010,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,13010,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,13011,0)
 ;;=A81.89^^58^675^5
 ;;^UTILITY(U,$J,358.3,13011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13011,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,13011,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,13011,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,13012,0)
 ;;=G20.^^58^675^69
 ;;^UTILITY(U,$J,358.3,13012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13012,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,13012,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,13012,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,13013,0)
 ;;=G23.1^^58^675^73
 ;;^UTILITY(U,$J,358.3,13013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13013,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,13013,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,13013,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,13014,0)
 ;;=F03.91^^58^675^17
 ;;^UTILITY(U,$J,358.3,13014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13014,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,13014,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,13014,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,13015,0)
 ;;=F03.90^^58^675^19
 ;;^UTILITY(U,$J,358.3,13015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13015,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,13015,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,13015,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,13016,0)
 ;;=F02.81^^58^675^40
 ;;^UTILITY(U,$J,358.3,13016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13016,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,13016,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,13016,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,13017,0)
 ;;=F02.80^^58^675^41
 ;;^UTILITY(U,$J,358.3,13017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13017,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,13017,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,13017,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,13018,0)
 ;;=G31.84^^58^675^56
 ;;^UTILITY(U,$J,358.3,13018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13018,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,13018,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,13018,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,13019,0)
 ;;=F02.81^^58^675^24
 ;;^UTILITY(U,$J,358.3,13019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13019,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,13019,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,13019,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,13020,0)
 ;;=F02.80^^58^675^25
 ;;^UTILITY(U,$J,358.3,13020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13020,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,13020,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,13020,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,13021,0)
 ;;=G31.84^^58^675^57
 ;;^UTILITY(U,$J,358.3,13021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13021,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ANOTHER MEDICAL CONDITION
 ;;^UTILITY(U,$J,358.3,13021,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,13021,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,13022,0)
 ;;=A81.01^^58^675^9
 ;;^UTILITY(U,$J,358.3,13022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13022,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,13022,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,13022,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,13023,0)
 ;;=F05.^^58^675^13
 ;;^UTILITY(U,$J,358.3,13023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13023,1,3,0)
 ;;=3^Delirium d/t Another Medical Condition
 ;;^UTILITY(U,$J,358.3,13023,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,13023,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,13024,0)
 ;;=F05.^^58^675^14
 ;;^UTILITY(U,$J,358.3,13024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13024,1,3,0)
 ;;=3^Delirium d/t Multiple Etiologies
 ;;^UTILITY(U,$J,358.3,13024,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,13024,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,13025,0)
 ;;=R41.0^^58^675^15
 ;;^UTILITY(U,$J,358.3,13025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13025,1,3,0)
 ;;=3^Delirium,Other Specified
 ;;^UTILITY(U,$J,358.3,13025,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,13025,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,13026,0)
 ;;=R41.0^^58^675^16
 ;;^UTILITY(U,$J,358.3,13026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13026,1,3,0)
 ;;=3^Delirium,Unspec
 ;;^UTILITY(U,$J,358.3,13026,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,13026,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,13027,0)
 ;;=G31.09^^58^675^20
 ;;^UTILITY(U,$J,358.3,13027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13027,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,13027,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,13027,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,13028,0)
 ;;=F02.81^^58^675^36
 ;;^UTILITY(U,$J,358.3,13028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13028,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,13028,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,13028,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,13029,0)
 ;;=F02.80^^58^675^37
 ;;^UTILITY(U,$J,358.3,13029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13029,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,13029,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,13029,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,13030,0)
 ;;=F02.81^^58^675^42
 ;;^UTILITY(U,$J,358.3,13030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13030,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,13030,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,13030,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,13031,0)
 ;;=F02.80^^58^675^43
 ;;^UTILITY(U,$J,358.3,13031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13031,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,13031,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,13031,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,13032,0)
 ;;=G31.84^^58^675^58
 ;;^UTILITY(U,$J,358.3,13032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13032,1,3,0)
 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
 ;;^UTILITY(U,$J,358.3,13032,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,13032,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,13033,0)
 ;;=F02.81^^58^675^26
 ;;^UTILITY(U,$J,358.3,13033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13033,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,13033,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,13033,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,13034,0)
 ;;=F02.80^^58^675^27
 ;;^UTILITY(U,$J,358.3,13034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13034,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,13034,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,13034,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,13035,0)
 ;;=G31.84^^58^675^59
 ;;^UTILITY(U,$J,358.3,13035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13035,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
 ;;^UTILITY(U,$J,358.3,13035,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,13035,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,13036,0)
 ;;=F02.81^^58^675^28
 ;;^UTILITY(U,$J,358.3,13036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13036,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
